Fresenius Medical Care stock drops on weaker Xetra close

Published on 09/21/2026 at 14:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Fresenius Medical Care stock fell 2.75 percent to EUR 38.53 on September 19, 2026. The company plans its Q3 2026 results for November 3, 2026.

Moderner Dialyseraum mit Hämodialysegeräten und Patientenliegen bei Tageslicht — Ein fotorealistisches Bild eines modernen Dialyseraums mit mehreren Hämodialysegeräten und Patientenliegen in Reihe, ruhigem Tageslicht durch große Fenster – typisch für die Behandlungszentren von Fresenius Medical Care AG (ISIN DE0005785802), Illustration mit AI erstellt.

Fresenius Medical Care stock (ISIN DE0005785802) closed at EUR 38.53 on September 19, 2026, down EUR 1.09 or 2.75 percent from the prior close. The next reported step in the calendar is the company's Q3 2026 results on November 3, 2026, followed by the quarterly report on November 6, 2026, according to ad hoc news.

Guidance still sets the frame

According to ad hoc news, Fresenius Medical Care confirmed full-year 2026 guidance in its August 6, 2026 half-year report, after group revenue for the first half of 2026 rose to EUR 11.8 billion from EUR 11.0 billion a year earlier. That is a 7.3 percent increase and gives investors a current operating benchmark. The company also kept its target for low-to-mid single-digit revenue growth and a high-single-digit increase in net income for 2026.

What the chart says

The stock's latest close at EUR 38.53 on September 19, 2026 leaves the move from the prior session at EUR 1.09. The market value cited in the same market snapshot was about EUR 16.0 billion on September 18, 2026, so the share still trades with a sizable equity base behind it.

Stock around the next update

Fresenius Medical Care stock remains tied to the November reporting window, with the next catalyst dated November 3, 2026. The last quoted Xetra close was EUR 38.53 on September 19, 2026.